for patients with advanced GC is still unsatisfactory. 8 Therefore, it is very imperative for us to elucidate the molecular mechanisms regulating the occurrence of GC and the related molecular mechanisms of the disease for creating the targeted therapy for patients with GC. 9 In the human genome, the human leukocyte antigen (HLA), also deemed as major histocompatibility complex (MHC), is located on chromosome 6 and includes 239 antigenic loci with the length of 3600 kb. 10, 11 It has been suggested that HLA genes are reported to modulate the immune system and are inclined to many kinds of autoimmune disorders, especially HLA-DRB1 and HLA-DQB1. 12, 13 Previous studies demonstrated that HLA-DQB1
gene polymorphisms were correlated with various kinds of cancers, including cervical cancer and GC. 14, 15 Besides, blood transfusions, an important method for saving the life of patients, are often needed during gastrectomy with extended lymphadenectomy. 16 However, transfusion can result in multiple kinds of side effects, including infection, hemolytic transfusion reaction, iron overload, post-transfusional graft vs host disease, as well as polycythemia. 17 The relationship between perioperative blood transfusion and the prognosis of patients with GC remains controversial. Thus, we are intended to investigate the relationship between HLA-DQB1 gene polymorphisms, perioperative blood transfusion, and patients with GC for providing some references for the treatment of GC.
| MATERIAL S AND ME THODS

| Ethics statement
This study was approved by the Ethics Committee of Taizhou
Hospital of Zhejiang Province, and in strict accordance with the principle of informed consent, which was signed by patients and their families.
| Study subjects
A total of 142 patients with GC (the case group) underwent gastrectomy with complete follow-up data were enrolled in our study, which were also pathologically diagnosed in Taizhou 
| Treatment regimens
All 142 patients with GC were not treated with radiochemotherapy, and gastrectomy was performed after pathological diagnosis. All the subjects were collected in the early morning before operation to study the gene polymorphism. Perioperative period in this study means a period of time from patients with GC received operation to basic recovery, and perioperative blood transfusion was mainly determined by the attending physician according to the patient's condition, and there was no strict system to regulate the critical value of blood transfusion.
| Extraction of DNA from peripheral blood
Peripheral venous blood (5 mL) was collected from all study subjects via vacuum blood collection tube in the fasting morning and centrifuged at 1610 g for 10 minutes. The DNA was extracted via DNA extraction kit (Takara Holdings Inc., Kyoto, Japan). A total of 500 μL blood sample and 500 μL cell lysate were mixed evenly and oscillated for 10 seconds, followed by centrifugation at 25 764 g for 5 minutes to discard the supernatant. After that, 500 μL cell lysate was added into and supernatant was discarded to leave a little nuclear precipitation. Then, 250 μL buffer solution was added and mixed evenly for further use. The water bath was conducted for samples at 55°C for rendering the solution transparent. After that, the absolute ethyl alcohol (100 μL) was added for mixing evenly. The flocculent precipitation and above solution were added into an adsorbing column CB3 for centrifugation at 25 764 g for 60 seconds. The discard solution was discarded with the addition of 600 μL rinse solution, followed by the centrifugation at 25 764 g for 60 seconds. After the removal of discard solution, the adsorbing column CB3 was stewed at room temperature for 10 minutes. The remaining rinse solution was dried, and the adsorbing column CB3 was placed at clean centrifuge tubes, followed by the addition of 100 μL buffer solution.
After that, the adsorbing column CB3 was placed at room temperature for 10 minutes and centrifuged at 25 764 g for 5 minutes. 
| Polymerase chain reaction-sequence-specific primer (PCR-SSP)
The extracted DNA sample was mixed well with the primers (Table 1) 
| Follow-up
All patients were followed up until May 2017 with the follow-up 39.4%. The first time follow-up was conducted 1 month after operation, the first year after operation was followed up every 3 months, and the follow-up would be conducted once or twice every year afterward.
| Statistical analysis
The statistical analyses in our study were conducted with SPSS 21.0 HLA-DQB1*02 The reference band was set by PCR-SSP. The results of this experiment can be effectively interpreted by the rules of interpretation (Figure 1 ). In the case group, 5 specific loci were found, which were consistent with those of the control group. Compared with the control group, the frequency of HLA-DQB1*03 gene in the case group was significantly increased (P < .05), while no such difference was found in gene frequency of the other four sites (P > .05) ( Table 2 ).
The results revealed that the frequency of HLA-DQB1*03 gene is 
| Patients with GC with
| Perioperative blood transfusion and HLA-DQB1*03 gene polymorphisms are important factors influencing survival of patients with GC
The 5-year survival rate of 142 patients with GC was 39.4%.
Patients in the nontransfusion group had the 5-year survival rate of 61.9%, and patients in the transfusion group had the 5-year survival rate of 21.5% (both P < .05) ( Figure 3A with the other genotypes (all P < .05) ( Figure 3B ), suggesting that perioperative blood transfusion and HLA-DQB1 gene polymorphisms were important factors influencing survival of patients with GC. (Table 5 ).
| D ISCUSS I ON
From previous study, GC is associated with a higher incidence and mortality, which need efficacy treatment regimens. 19 Recently, some Abnormal expression of HLA has been proved to play important roles in the development of malignancies. 23 It was found in a previous study that both HLA-DQA1 and HLA-DQB1 genes have a minor role in H. pylori infection and GC. 24 And, HLA-DQ types were also proved to influence the progression to atrophy in H. pylori infection. 25, 26 Wu et al drew the conclusion that HLA-DQB1 alleles are associated with susceptibility or resistance to GC and also influence its clinical features. 27 Besides, it has been reported by previous researcher that HLA-DQ locus may play a different role in the development of H pylori-related chronic gastritis and diffuse-type gastric adenocarcinoma. Additionally, our study clarified that the transfusion group had more patients with age >60 years, with tumors in upper and middle parts, with residual incisal margin and with anemia before operation when compared with the nontransfusion group. In the transfusion group, deeper depth of infiltration, higher LNM rate, and later stage of disease were found when compared with the nontransfusion group.
Studies focused on perioperative blood transfusion and cancers confirmed that transfusions may raise the frequency and earlier recurrences of solid tumors. 29, 30 It is reported that patients with GC were more likely to need blood transfusion with higher age, female gender, surgical extension to adjacent organs/structures, and tumor location. 31 As reflected in a previous study, red blood cell transfusions (RBCTs) may affect postoperative recovery because it would contribute to the risk of transfusion-related immunomodulation, and RBCTs are related to worse postoperative short-term outcomes in patients with GC. 32 In line with our study, a direct negative correlation was found between perioperative blood transfusion and prognosis in patients receiving GC surgery. 17 The cancer-related anemia, a multifactorial disease, can cause chronic blood loss, metabolite homeostasis, and immune response. 33 Patients with preoperative anemia had poor outcomes, which can be improved by frequently required blood transfusion therapy. 34 Furthermore, the multivariate analysis demonstrated that anemia before operation, depth of infiltration in T3 stage and T4 stage, LNM in N1 stage and N2 stage, and HLA-DQB1*03 genotype were regarded as independent risk factors for patients with GC. Anemia is usually known as a negative predictor of response to chemoradiotherapy. 35 One study also concluded that patients with preoperative anemia would have poor prognosis, 36 which was in line with our study. Previous evidence conducted by Kulig J et al also demonstrated that depth of infiltration, LNM, and distant metastases, and residual tumor category were the independent prognostic factors for patients with GC. 37 Additionally, consistent with our result, previous study also proved that tumor invasion and LNM were independent prognostic factors for patients with GC. 38 HLA-DQ locus has also been reported to be correlated with the development of diffuse-type gastric adenocarcinoma. 28 In conclusion, our preliminary study demonstrated that HLA-DQB1*03 genotype and perioperative blood transfusion contribute to poor prognosis of patients with GC. Our conclusion provides a reference for the clinical treatment of patients with GC. But due to our limited sample size, our results need further confirmation by a large-scale study.
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